Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2015
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to TherapyMorena Fasano, Carminia Maria Della Corte, Federica Papaccio, et al.
Exploration of Targeted Anti-Tumor Therapy|May 4, 2026
The evolving landscape of first-line and subsequent therapies in <i>EGFR</i>-mutated NSCLC: efficacy, resistance, and tolerabilityCarminia Maria Della Corte, Caterina De Rosa, Faiz Ul Haq, et al.
British Medical Bulletin|June 22, 2016
Therapies in the pipeline for small-cell lung cancerOurania Romanidou, Martina Imbimbo, Giannis Mountzios, et al.
Critical Reviews in Oncology/Hematology|April 5, 2008
The use of xenograft models for the selection of cancer treatments with the EGFR as an exampleTeresa Troiani, Clorinda Schettino, Erika Martinelli, et al.
Biomedicines|May 27, 2017
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in CancerCarminia Maria Della Corte, Morena Fasano, Federica Papaccio, et al.
Asian Cardiovascular & Thoracic Annals|January 13, 2021
PercuTwist tracheostomy in an intubated patient with tracheal stentMary Bove, Fausto Ferraro, Floriana Morgillo, et al.
Expert Opinion on Investigational Drugs|May 23, 2012
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancerTeresa Troiani, Erika Martinelli, Michele Orditura, et al.
Plos One|December 17, 2011
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitorsFloriana Morgillo, Erika Martinelli, Teresa Troiani, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Epidermal growth factor receptor inhibitors in non-small-cell lung cancerTina Cascone, Erika Martinelli, Maria Pia Morelli, et al.
Therapeutic Advances in Medical Oncology|January 17, 2013
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?Teresa Troiani, Erika Martinelli, Floriana Morgillo, et al.
Pageof 16